| TUCSON, Ariz., March 1, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today that the FDA has approved the application of its INFORM HER2 Dual ISH DNA Probe cocktail assay (HER2 Dual ISH) on the VENTANA BenchMark ULTRA automated slide staining platform for commercialization in the United States. Originally approved by the FDA in June 2011 for use with the BenchMark XT instrument, the HER2 Dual ISH assay is now approved for use on ...continued RHHBY laroche sitemap roche |
Thursday, March 1, 2012
Ventana Receives FDA Approval of INFORM HER2 Dual ISH Assay on the BenchMark ULTRA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment